COMMUNIQUÉS West-GlobeNewswire

BioSig Technologies Completes Private Placement
13/08/2018
Capital Raised to Support Nasdaq Uplist and Commercial Launch Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical [...]
Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency
13/08/2018
Mustang Expands Pipeline into Gene Therapy for Rare Disease NEW YORK and MEMPHIS, Tenn., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused [...]
Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer
13/08/2018
NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights
13/08/2018
Successfully Completed Initial Public Offering (IPO) Submitted New Drug Application (NDA) for Glucagon Rescue Pen CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty [...]
Cellectar’s CLR 131 Receives FDA Rare Pediatric Disease Designation for the Treatment of Ewing’s Sarcoma
13/08/2018
MADISON, Wis., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
SoldierStrong Donates Exoskeleton for Advanced Stroke Rehabilitation to Tampa’s James A. Haley Veterans' Hospital
13/08/2018
Tampa-area veterans now have access to earlier mobilization following a stroke STAMFORD, Conn., Aug. 13, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical [...]
Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2018
13/08/2018
HOUSTON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Nephros Appoints Oliver Spandow to its Board of Directors
13/08/2018
Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells [...]
Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Compounded Vasopressin Injection in Ready-to-Use Premix IV Bags
13/08/2018
BUFFALO, N.Y., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Health Care Services Business in New England, U.S.
13/08/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), is [...]
Myriad Reschedules Release of Fiscal Fourth-Quarter 2018 Financial Results
13/08/2018
Company Reaffirms Fiscal 2018 Guidance and Will Now Release Results on August 21, 2018 SALT LAKE CITY, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and [...]
Protalix BioTherapeutics Appoints David Granot to its Board of Directors
13/08/2018
CARMIEL, Israel, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American: PLX, TASE: PLX), announced today that the Company’s Board of Directors has appointed Mr. David Granot to serve on the [...]
XORTX Submits FDA pre-IND Meeting Documents
13/08/2018
● Advancing to a Phase II Clinical Study in Polycystic Kidney Disease ● CALGARY, Alberta, Aug. 13, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a [...]
With Excellence in Action Awards, NRC Health recognizes outstanding service and engagement in long-term care and senior living
13/08/2018
Exceptional skilled nursing, assisted living, and independent living organizations earned this national distinction by achieving 90th percentile scores for resident and employee satisfaction LINCOLN, Neb., Aug. 13, 2018 [...]
Urgent need for blood donors before Labour Day
13/08/2018
More than 22,000 donors needed across Canada by August 26 OTTAWA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- With many blood donors away or busy with summer activities, Labour Day weekend will be a particularly challenging time [...]
Urgent besoin de donneurs de sang d’ici la fête du Travail
13/08/2018
Nous avons besoin de plus de 22,000 donneurs à la grandeur du pays d’ici le 26 août. OTTAWA, 13 août 2018 (GLOBE NEWSWIRE) -- La fin de semaine de la fête du Travail représente un défi particulier pour ce qui est du don [...]
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
13/08/2018
Once granted, the new patent, which covers both RHB-104 and RHB-204, is expected to be valid until at least 2029 RedHill recently announced positive top-line results from the randomized, double-blind, placebo-controlled [...]
Auxly Announces Strategic Partnership With Cannabis OneFive
13/08/2018
VANCOUVER, British Columbia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that it has entered into a strategic partnership with Cannabis [...]
Tonix Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights
13/08/2018
HONOR Study Results to be Included in Poster Presentation at a Scientific Conference in August 2018 FDA Meeting in October 2018 Confirmed to Discuss New Phase 3 Study for Tonmya® in PTSD New Phase 3 Study for Tonmya May [...]

Pages